Traphaco Joint Stock Company (HOSE: TRA)
Health Care · Pharmaceuticals · VN
₫36,900.00
-2.12% today · +10.8% 1Y
Traphaco Joint Stock Company (HOSE: TRA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $117.12M.
Over the last twelve months the share price has gained 10.8%, trading between 31.50K and 41.40K.
Tweenvest scores Traphaco Joint Stock Company across four factors: quality 85/100, value 73/100, growth 24/100, dividend 90/100. Its strongest factor is dividend.
TRA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $117.12M
- Revenue (TTM)
- $105.14M
- P/E
- 13.77
- EPS
- 2,678.98
- Dividend yield
- 5.42%
- Beta (5Y)
- 0.12
- 52-week high
- ₫41,400.00
- 52-week low
- ₫31,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 82.90M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF375.40 | +0.43% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.86 | -0.72% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.